{"id":2366,"date":"2017-11-21T17:45:15","date_gmt":"2017-11-21T17:45:15","guid":{"rendered":"https:\/\/www.medicalmarijuanainc.com\/?p=32511"},"modified":"2017-11-21T17:45:15","modified_gmt":"2017-11-21T17:45:15","slug":"medical-marijuana-inc-reports-third-quarter-2017-financial-results","status":"publish","type":"post","link":"https:\/\/medicalmarijuanainc.com\/2017\/11\/21\/medical-marijuana-inc-reports-third-quarter-2017-financial-results\/","title":{"rendered":"Medical Marijuana, Inc. Reports Third Quarter 2017 Financial Results and Operational Highlights: Shows Record 255% Gross Profit Increase"},"content":{"rendered":"
\n
\n

SAN DIEGO<\/span>,\u00a0Nov. 21, 2017<\/span>\u00a0\/PRNewswire\/ —\u00a0Medical Marijuana, Inc.<\/a>\u00a0(OTC: MJNA), the first-ever publicly traded cannabis company in\u00a0the United States<\/span>, today announced financial results for the third quarter ending\u00a0September 30, 2017<\/span>\u00a0and an overview of recent operational highlights.<\/p>\n<\/div>\n<\/div>\n

<\/div>\n
\n
\n

The Company saw a gross revenue increase from\u00a0$2,188,671<\/span>\u00a0in Q3 2016 to\u00a0$7,783,297<\/span>\u00a0in Q3 2017, a year-over-year increase of 255%. Total gross profit increased from\u00a0$1,266,488<\/span>\u00a0in Q3 2016 to\u00a0$5,034,464<\/span>\u00a0in Q3 2017; which is an increase of 297%. Net loss in Q3 2016 of\u00a0($4,286,818)<\/span>\u00a0was decreased by 30% over Q3 2017 to\u00a0($2,959,173)<\/span>. The company reported total assets in the amount of\u00a0$345,388,650<\/span>.<\/p>\n

Additionally, the company reported a year-over-year increase in year-to-date gross revenue from\u00a0$5,450,080<\/span>\u00a0in 2016 to\u00a0$17,098,785<\/span>\u00a0in 2017, an increase of 213%. Year-to-date gross profits also increased 258% year over year, from\u00a0$3,254,122<\/span>\u00a0in 2016 to\u00a0$11,675,391<\/span>\u00a0in 2017.<\/p>\n

“We are excited to announce such outstanding leaps in growth and success this quarter,” said Medical Marijuana, Inc. CEO Dr.\u00a0Stuart Titus<\/span>. “We believe that with these record-breaking revenue numbers, we have the capacity to make 2018 the most profitable year the company has ever seen.\u00a0We are currently spending on international expansion and research efforts which\u00a0should pay long-term dividends for shareholders.”<\/p>\n

THIRD QUARTER OPERATIONAL HIGHLIGHTS
\n<\/b>Medical Marijuana, Inc. investments and subsidiaries continued international expansion and product development in the third quarter of 2017.<\/p>\n

1) HempMeds\u00ae
\n<\/sup><\/b>
Wholly owned subsidiary HempMeds US<\/a>, the portfolio’s predominate consumer brand, continued to grow in 2017 and experienced the following milestones:<\/p>\n